Nordson separation agreement for departing segment leader Lovass: $832,759 cash, continued vesting

NORDSON CORP

Stephen Lovass ceased as Medical and Fluid Solutions segment leader; assists transition until June 1, 2025, then separates.
Receives $832,759 cash (severance plus COBRA) and pro-rata FY2025 annual incentive under separation agreement.
Stock options granted on/before Dec 1, 2022 continue vesting; exercisable until June 1, 2030 or original expiry.
Restricted shares/units from same period vest pro-rata; PSUs from Dec 1, 2022 vest pro-rata based on actual performance.
One-year non-compete, non-solicitation; indefinite confidentiality, non-disparagement; outplacement up to $10k, financial planning up to $5k.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stephen Lovass

segment leader for the Medical and Fluid Solutions Segment

NDSN · NORDSON CORP

Effective: 2025-04-28
Filed: Jun 11, 2025 23:59 UTC

the Original Form 8-K reported that, on April 28, 2025, Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation

Source: SEC EDGAR

accession 0000072331-25-000074

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.